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Results from an Observational Trial: Digital
Epiluminescence Microscopy Follow-Up of Atypical
Nevi Increases the Sensitivity and the Chance of
Success of Conventional Dermoscopy in Detecting
Melanoma
Holger A. Haenssle1, Ullrich Krueger1, Claudia Vente1, Kai-Martin Thoms1, Hans P. Bertsch1, Markus Zutt1,
Albert Rosenberger2, Christine Neumann1 and Steffen Emmert1
We analyzed the value of digital epiluminescence microscopy (DELM) for the long-term follow-up of atypical
nevi. Patients (n¼ 530) were prospectively categorized into defined melanoma risk groups and followed by
clinical and epiluminescence microscopy (ELM) examinations. Atypical nevi (n¼ 7001) were additionally
followed by DELM. During follow-up (median 32.2 months), we detected 53 melanomas among 637 excised
lesions (8.3% overall chance of success). The chance of success for melanoma detection among lesions
suspicious by ELM criteria was increased to 17% when additional DELM-documented changes were present.
Moreover, 18 of the 53 melanomas were exclusively identified by DELM-documented changes, indicating that
DELM increased the sensitivity of the ELM analysis by identifying additional melanomas. However, for lesions
exclusively excised due to DELM changes, the chance of success was lower than for ELM (5.2 vs 11.8%). Excisions
due to mere DELM changes detected 66.7% of melanomas in familial atypical mole and multiple melanoma
(FAMMM) and 32.5% of melanomas in atypical mole syndrome (AMS) patients. We conclude that DELM is a
valuable tool for the long-term follow-up of atypical nevi, especially in the high-risk groups of FAMMM and
AMS patients. Randomized controlled trials are needed to validate the data from this clinical trial.
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INTRODUCTION
The most effective approach to improve the prognosis of
cutaneous melanoma is early recognition and surgical excision
of thin lesions (Breslow, 1980). In addition to a basic naked-
eye examination, epiluminescence microscopy (ELM) has
been shown to improve the diagnostic accuracy for early
melanoma detection (Ascierto et al., 2000). However, ELM
does not reach 100% diagnostic accuracy mostly due to a lack
of distinct dermoscopic features either in far-progressed
featureless melanomas (Carli et al., 2002) or in very early
melanomas (Kittler et al., 2000). It might therefore be
necessary to base the management of atypical pigmented skin
lesions on additional information, for example deriving from
the longitudinal observation of dynamic changes. Until now,
only few reports on digital epiluminescence microscopy
(DELM) follow-up of melanocytic skin lesions have been
published with heterogeneous results (Braun et al., 1998;
Kittler et al., 2000; Kittler and Binder, 2001; Menzies et al.,
2001; Schiffner et al., 2003; Haenssle et al., 2004; Robinson
and Nickoloff, 2004). The digital follow-up of melanoma
suspicious or equivocal lesions instead of their immediate
excision has raised much concerns about the possibility of a
delayed treatment of melanomas (Kittler and Binder, 2001;
Carli et al., 2003, 2004a; Argenziano, 2005). In contrast
to such concerns, the DELM follow-up of atypical, but
not melanoma suspicious or equivocal, lesions was shown to
allow for the detection of early melanomas that have not
yet acquired melanoma-typical ELM features (Haenssle
et al., 2004). Here, we demonstrate that a long-term follow-
up of atypical melanocytic lesions by DELM increases
the sensitivity for detection of cutaneous melanoma. We
identified criteria for the selection of patients who would
potentially benefit the most from the costly and time-
consuming procedure of long-term sequential imaging of
atypical melanocytic nevi.
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RESULTS
The melanoma risk correlates with the number of nevi and the
attributed risk group
We found no association between the incidence of cutaneous
melanoma during the study and sex, age, presence of ephelides,
eye color, hair color, and skin type by univariate and multi-
variate statistical analyses. However, a significant association
(Pp0.012) was found between the risk for melanoma during
the study and the number of nevi at the first visit, the
prospectively attributed risk group (I–III), and the presence of
a personal and/or family melanoma history (Table 1).
First-visit examinations
At the first-visit examinations 237 pigmented lesions, including
37 melanomas, were excised. These 37 melanomas were
identified either due to ELM criteria (n¼30) or due to the
assessment and the apprehension of the patients themselves
(n¼ 7, history of scaling, inflammation, enlargement, and change
in color). Lesions excised due to the ELM algorithm of pattern
analysis provided a higher chance of success than excisions
performed due to the apprehension of the patient alone (Table 2).
DELM algorithm increases the sensitivity for melanoma
detection during follow-up
The median number of DELM-documented lesions per
patient visit was 13 (range 1–55) and a total of 7001
melanocytic skin lesions were followed by DELM. Overall,
we identified 53 melanomas (25 invasive and 28 in situ
melanomas) with a mean Breslow thickness of 0.43 mm for
invasive melanomas (range 0.12–0.9 mm) during follow-up.
In order to detect the 53 melanomas, a total of 637 excisions
had to be performed. This corresponds to an overall chance
of success during follow-up of 8.3% (Table 2). None of
these melanomas was excised due to crude changes notable
in comparison with conventional overview images.
Six of the 53 melanomas were detected by carefully taking
the lesional history and by the apprehension of the patient
himself without any other of the described examination
procedures scoring suspicion (two invasive and four in situ
melanomas). This examination technique resulted in one
melanoma in 14 excisions (7.1% chance of success; Table 2).
In all, 13 melanomas developed de novo on uninvolved
skin (according to comparison with baseline photographs)
and were identified by ELM criteria (five invasive and eight
in situ melanomas). The applied ELM algorithm yielded
one melanoma in nine excisions (11.8% chance of
success; Table 2).
During follow-up, 349 of the 637 removed lesions (5.0%
of all 7001 DELM-documented lesions) were excised because
of morphologic changes that had been identified by
comparison of current with baseline DELM images showing
only subtle phenotypic changes, which did not trigger
Table 1. Frequency of melanoma patients in defined patient subgroups as detected during the study
Patients subgroup characteristics
Number of patients
with X1 melanoma Odds ratio1 95% CI P-values2
Number of nevi (estimated)
o50 nevi (n=225) 13 Reference Reference Reference
50–100 nevi (n=214) 33 2.97 [1.52–5.82] 0.0015*
4100 nevi (n=91) 15 3.22 [1.46–7.08] 0.0036*
Assignment of risk group
Group I – MN syndrome (n=353) 14 Reference Reference Reference
Group II – AM syndrome (n=171) 43 8.13 [4.31–15.37] o0.001*
Group III – FAMMM syndrome (n=6) (all with history3
of melanoma)
4 48.43 [8.17–287] o0.001*,4
Presence of melanoma history
Group I and no history3 of melanoma (n=261) 5 Reference Reference Reference
Group I and history3 of melanoma (n=92) 9 4.05 [1.37–12] 0.012*
Group II and no history3 of melanoma (n=74) 7 Reference Reference Reference
Group II and history3 of melanoma (n=97) 36 5.65 [2.34–13.63] o0.001*
Group I: MN-syndrome group, patients with multiple (450) common melanocytic nevi; Group II: AM-syndrome group, patients with atypical mole
syndrome; Group III: FAMMM syndrome group, patients with familial atypical mole and multiple melanoma syndrome.
1Odds ratios were modelled by logistic regression.
2P-values were calculated according to Wald-w2 statistic.
3History, includes personal melanoma history and/or family melanoma history.
4Due to the small n for the FAMMM syndrome group, Fishers exact test was used to calculate the P-value. All calculations were performed with SDS-software
version 8.02.
*Statistically significant.
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a suspicion for melanoma by the ELM algorithm (e.g.
symmetrical or asymmetrical enlargement, progressing focal
hyper- or hypopigmentation). Histopathological analysis of
the 349 lesions revealed 18 (5.2%) early melanomas (nine
invasive and nine in situ melanomas). Thus, the defined
DELM criteria led to the identification of additional melano-
mas that would have been missed at this stage by the other
examination techniques. This indicates that DELM increased
the sensitivity of melanoma detection during follow-up.
However, basing the decision for surgical intervention
exclusively on DELM-documented changes during follow-
up triggered the excision of 331 non-melanomas, which
decreased the specificity of melanoma detection. The chance
of success for melanoma detection by DELM analysis
alone was one melanoma in 19 excisions (5.2% chance
of success; Table 2).
In all, 16 melanomas showed DELM changes in addition
to a suspicion for melanoma by ELM criteria (nine invasive
and seven in situ melanomas). Lesions excised due to the
presence of ELM plus DELM criteria scored the highest
chance of success for melanoma detection during follow-up,
with one melanoma detected in six excisions (17% chance of
success; Table 2). This indicates that DELM might increase
the specificity of melanoma detection, provided that it is used
as a method additional to the ELM analysis.
Melanomas detected by DELM follow-up have the lowest
Breslow tumor thickness
The tumor thickness according to Breslow is an important
prognostic factor in primary cutaneous melanomas being
associated with a linear increase in the risk of death (Breslow,
1980). We found that melanomas detected by DELM during
follow-up had the lowest mean Breslow thickness (0.31 mm)
when compared to melanomas detected by other techniques
during follow-up (Figure 1). Overall, there was a thinner
Breslow tumor thickness and thus potentially a better
prognosis whenever the DELM technique was involved in
melanoma detection during follow-up (P¼ 0.591, Kruskal–-
Wallis test; Figure 1).
High-risk patients benefit the most from DELM follow-up
In order to answer the question as to which of the defined risk
groups benefit the most from long-term DELM follow-up, we
calculated the percentage of melanomas detected exclusively
by DELM changes in relation to all melanomas detected
during follow-up for the risk groups I–III. During follow-up,
the DELM criteria alone enabled the detection of 66.7% of
melanomas (four out of six) in the group of familial atypical
melanoma and multiple mole (FAMMM) patients (Group III;
n¼6), 32.5% of melanomas (13 out of 40) in the atypical
mole syndrome (AMS) group of patients (Group II; n¼171),
but only 14.3% (1 out of 7) in the group of patients with
multiple MN (Group I; n¼353). Thus, a trend for a higher
contribution of DELM follow-up to melanoma detection was
documented in high-risk group III patients when compared to
low-risk group I patients (P¼0.059, Fisher’s exact test, exact
logistic model).
Table 2. Chance of success for the detection of cutaneous melanoma at first visits and follow-up examinations
according to the different examination techniques
Excisions performed to identify one melanoma (percentage of melanomas among excised lesions, absolute numbers)
Technique of examination At first visit During follow-up
Patient apprehension alone 12 Excisions (8.3%, 84 excisions, 7 melanomas) 14 Excisions (7.1%, 84 excisions, 6 melanomas)
ELM criteria alone 5 Excisions (19.6%, 153 excisions, 30 melanomas) 9 Excisions (11.8%, 110 excisions, 13 melanomas)
DELM criteria alone Not available at first visit 19 Excisions (5.2%, 349 excisions, 18 melanomas)
ELM plus DELM criteria Not available at first visit 6 Excisions (17.0%, 94 excisions, 16 melanomas)
OVERALL 6 Excisions (15.6%, 237 excisions, 37 melanomas) 12 Excisions (8.3%, 637 excisions, 53 melanomas)
Patient apprehension alone: excisions performed due to patient apprehension without melanoma suspicion by other examination techniques.
ELM criteria alone: excisions performed due to suspicion by epiluminescence microscopy pattern analysis.
DELM criteria alone: excisions performed due to changes documented by digital epiluminescence microscopy without melanoma suspicion by other
examination techniques.
ELM plus DELM criteria: excisions due to suspicion by epiluminescence microscopy plus additional documented changes by digital epiluminescence
microscopy.
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Figure 1. Mean and 95% confidence interval of the Breslow tumor thickness
for melanomas detected during follow-up by the different indicated
examination techniques (P¼ 0.591; Kruskal–Wallis test). The measures
depicted in this graph were log-transformed (in contrast to the ‘‘in text’’
measures). Two invasive melanomas were detected by the patients’
apprehension, without a suspicion by the other examination techniques
(observed values shown); five invasive melanomas were detected by ELM
criteria alone; nine invasive melanomas were detected by ELM criteria and
also showed changes over time documented by DELM; nine invasive
melanomas were exclusively detected by the comparison of DELM images
with baseline images (DELM criteria alone).
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DISCUSSION
Cutaneous melanoma and risk factors
In accordance with the known independent major risk
indicators for cutaneous melanoma (Tucker et al., 1997;
Greene, 1999), we developed a special surveillance program
that is restricted to a high-risk patient population. This
program combines risk group stratification, patient apprehen-
sion, total body overview imaging, naked eye, ELM, and
DELM examinations. The calculated odds ratios for melano-
ma development significantly correlated with the estimated
total nevus count, the prospectively attributed risk group
(I–III), and the presence of a personal and/or family melanoma
history (Table 1), and therefore confirmed the value of the
proposed stratification criteria.
Efficacy of long-term DELM follow-up of nevi
Since the first report in 1998 (Braun et al., 1998), only a few
clinical DELM follow-up studies of melanocytic skin lesions
have been reported with heterogeneous results.
In a recent long-term DELM follow-up study, Schiffner
et al. (2003) followed 272 MN without signs of dermoscopic
atypia in 145 patients (75% low-risk patients, 25% high-risk
patients), with a median duration of 24 months, and detected
no melanomas. No melanomas were also detected by Braun
et al. (1998), who followed patients with multiple common
nevi using DELM for 2 years. Obviously, the use of a long-
term follow-up DELM examination does not seem beneficial
for melanoma detection when low-risk lesions (without signs
of atypia) in mainly low-risk patients are monitored.
Robinson and Nickoloff (2004) chose a setting for a long-
term follow-up study (median follow-up of 36.2 months) in
100 high-risk patients similar to our own study. During
annual follow-up visits, 193 (5.5%) of the 3482 digitally
documented lesions were excised, with four lesions being
melanoma in situ. During the follow-up period of our study
(median: 32.2 months), the analysis of sequentially stored
DELM images of atypical melanocytic lesions (n¼7001) in
patients with an increased risk for melanoma (n¼530)
identified 18 melanomas out of 349 DELM-based excised
lesions. This corresponds to 34% of all melanomas detected
during follow-up (18 out of 53). These melanomas were
missed by the ELM examination that was systematically
performed before the comparison of digitalized images with
baseline images. Therefore, the DELM technique increased
the sensitivity of melanoma detection. The question whether,
and at what tumor thickness, these melanomas would have
developed ELM features allowing their detection by conven-
tional dermoscopy cannot be answered.
We also retrospectively calculated the chance of success
(mostly representing the positive predictive value) for
melanoma detection, which implies the number of lesions
that had to be excised in order to detect one melanoma
(Table 2). As expected, a high number of benign lesions were
excised due to our cautious DELM criteria, causing a 5.2%
chance of success. However, by adding the DELM analysis to
the conventional ELM inspection, the chance of success for
melanoma detection during follow-up was increased from
11.8% (110 excisions to detect 13 melanomas by ELM) to
17.0% (94 excisions to detect 16 melanomas by ELM
suspicion plus DELM changes). This reduced the number of
lesions that had to be excised in order to identify one
melanoma from nine to six suspicious lesions (Table 2).
The observed increase in sensitivity and the improved
chance of success for melanoma detection by additionally
using DELM agree with the data of Kittler and Binder (2001),
who evaluated the utility of sequential imaging of melano-
cytic skin lesions by using a set of 80 digital test images
(including 10 early melanomas). Images were presented to 24
dermatologists. After presentation of follow-up images, the
diagnostic accuracy improved significantly.
Pitfalls and drawbacks of DELM follow-up
DELM follow-up of atypical nevi is a time consuming
procedure. The median number of DELM-followed lesions
per patient was 13. While the conventional examination of
an average study patient could be performed in 20 minutes,
the addition of DELM extended the examination to 30, and in
some cases even to 60 minutes (FAMMM group, 4100 nevi).
Less time might be required in routine practice as the
study design demanded a consecutive clinical, ELM, and
DELM examination, with many lesions being evaluated
multiple times.
Our preliminary and cautious algorithm of DELM criteria
for excisional biopsies caused a major percentage of non-
melanoma excisions during follow-up (331 of 584, 56.6%).
One of the major challenges in future will be to refine this
algorithm to increase the specificity without losing sensitivity.
The mere symmetrical increase in size of a lesion, for
example, was a poor marker for identifying melanomas and
contributed to most of our false-positive excisions. However,
the ratio of one melanoma in 19 excised pigmented lesions
yielded by the DELM algorithm alone still reaches a reason-
able specificity in comparison to the reported ratios for expert
dermoscopy users that ranged between 18 and 4.3 excised
pigmented lesions in order to detect one melanoma over 5
years of observation (Carli et al., 2004b).
The digital follow-up of equivocal or melanoma suspi-
cious lesions instead of an immediate excision represents one
of the most dangerous pitfalls of DELM. By such an approach,
the sensitivity for melanoma detection at the first visit is
reduced (Kittler and Binder, 2001). The only randomized
controlled clinical trial assessing the impact of DELM follow-
up failed to prove an increased sensitivity for melanoma
detection, but noticed the occurrence of initial melanomas
left unexcised until the second consultation, because the
study design offered clinicians the digital follow-up of
equivocal lesions (Carli et al., 2004a). Moreover, patients
may not be compliant and may therefore not attend follow-up
appointments. As the ‘‘treatment threshold’’ should not be
increased by the availability of DELM (Carli et al., 2003;
Argenziano, 2005), we did not submit equivocal or melano-
ma suspicious lesions to digital follow-up. Only atypical but
melanoma unsuspicious lesions were DELM documented
during our study, which offered the potential to detect
additional melanomas among otherwise (by clinical and ELM
analysis) unsuspicious lesions.
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Use of DELM may improve melanoma prognosis
The Breslow thickness is one of the most important
prognostic factors in primary cutaneous melanomas, with
an increasing tumor thickness being associated with a linear
increase in the risk of death. We found a thinner Breslow
tumor thickness (Figure 1) and thus a possible better
prognosis whenever the DELM technique was involved in
melanoma detection during follow-up (P¼ 0.591, Kruskal–-
Wallis test).
High-risk patients benefit the most from long-term DELM
follow-up
Patients with FAMMM syndrome and AMS seem to benefit
the most from DELM follow-up because in these groups 66.7
and 32.5% of all melanomas were identified exclusively
based on comparative analysis of DELM images, respectively.
In contrast, only 14.3% of melanomas in the group of patients
with multiple common MN were identified with DELM
alone. Assuming that the time for progression to cutaneous
melanoma is similar in the different risk groups, one reason
for this finding could be that shorter intervals in follow-up for
AMS and FAMMM syndrome patients help to identify
melanomas by subtle DELM-documented changes before
these lesions develop ELM-typical melanoma features. The
earliest of the six melanomas detected by DELM in FAMMM
patients was diagnosed after 1 year of follow-up, and all were
excised at a low tumor thickness (two melanomas in situ,
invasive melanomas from 0.25 to 0.9 mm tumor thickness),
making an undue DELM follow-up of pre-existing melanomas
for 121 12 years very unlikely.
In conclusion, during this long-term follow-up program,
DELM proved to be a valuable tool for the early detection
of cutaneous melanomas in atypical melanocytic lesions
primarily not suspicious for melanoma. The application of the
DELM criteria increased the sensitivity of the conventional
ELM analysis, especially for defined high-risk patient groups,
including AMS and FAMMM syndrome patients. A lower
Breslow tumor thickness was present whenever DELM was
involved in the decision for an excisional biopsy. Limitations
arising from the observational uncontrolled nature of this
study require further randomized trials for confirmation of
our results. Another objective for future studies should be
the refinement of the DELM algorithm to reduce the
number of unnecessary excisions, and thus to further increase
the effectiveness of DELM for follow-up of patients at risk
for melanoma.
MATERIALS AND METHODS
Patients’ characteristics
All clinical investigation was conducted according to the Declara-
tion of Helsinki Principles. Institutional approval and patient consent
were obtained for all experimental interventions. The study included
530 patients (56.5% females, 43.5% males) with an increased risk
for developing melanoma. Patients were prospectively stratified
into three groups according to the presence of melanoma risk
factors: Group I, patients with multiple (more than 50) MN or three
or less clinical atypical nevi (n¼ 353); Group II, patients with AMS
(Tucker et al., 1997) additionally characterized by three or more
histologically dysplastic nevi in their personal medical history
(n¼ 171); Group III, patients with familial atypical mole and
multiple melanoma (FAMMM) syndrome characterized by a family
history of at least two melanomas in relatives of the first or second
degree (n¼ 6). The first two risk groups were further subdivided
according to a positive or negative personal and/or family history
of melanoma. Patients’ characteristics, including age, sex, hair color,
eye color, skin type (I–IV, Fitzpatrick’s classification), presence or
absence of ephelides, and the estimated number of nevi, were
prospectively entered into a database. In all, 36.8% of the patients
had a personal and/or family history of melanoma, 32.3% belonged
to the group of AMS patients, and 57.6% had more than 50 nevi.
The mean age was 40 years (range 2–89 years) and the median
surveillance time was 32.2 months (range 3–77 months).
Selected data of 212 patients after a median follow-up of 18
months were subjected to analysis and publication earlier (Haenssle
et al., 2004).
Patients’ examination
Data of 530 patients were collected during 7 years (1997–2004). At
the first visit the whole integument was examined by the unaided
eye, the number of nevi was estimated (o50, 50–100, 4100) and
ELM examination of all clinically atypical nevi was performed using
a portable device (Welch Allyn, Skaneateles Falls, NY). The ELM
pattern analysis of pigmented skin lesions as described by
Pehamberger et al. (1987) was used as a diagnostic algorithm for
differentiating benign melanocytic lesions from melanoma. Melano-
cytic lesions suspicious of malignancy and equivocal lesions by this
algorithm were immediately excised. Lesions presenting clinical
criteria of atypia (asymmetry in shape, variegated color) or ELM
criteria of atypia (irregular/prominent pigment network, irregular
overall pigmentation) (Ascierto et al., 2000) were marked on
digital overview images and electronically stored by using two
DELM-imaging systems (FotoFinder dermoscope, Teachscreen Soft-
ware GmbH, Bad Birnbach, Germany or Hikoscopes, Hiko,
Pirmasens, Germany). Additional standardized conventional over-
view photographs facilitated the detection of newly arising lesions
(Kelly et al., 1997).
Follow-up examinations were scheduled for every 3, 6, or 12
months depending on the individual risk. Patients were asked
about new or changing nevi, conventional overview photographs
were compared with the corresponding body surface, and all
clinically atypic nevi were examined by ELM. Newly developed
lesions were treated as described for first-visit examinations.
Nevi that had been digitally documented during a previous
visit (n¼ 7001) were again digitally stored by DELM and then
compared side by side with the corresponding baseline image
on a split screen.
Excisional biopsy after DELM analysis
Criteria leading to the excision of digitally stored lesions were
symmetrical or asymmetrical enlargement, changes in shape or
color, new signs of regression, or changes in the ELM structure
(Binder et al., 1998; Kittler et al., 2000). Excision was performed
when at least one of these criteria had developed in a lesion, even if
the lesion itself was not regarded suspicious for malignancy by
pattern analysis. In agreement with others, we did not excise lesions
developing a darker or lighter overall pigmentation or lesions with
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a decrease in the number of initially present black dots (Braun et al.,
1998; Kittler et al., 2000).
Statistical evaluation
The statistical analysis was performed using SAS 8.6 software.
The data were prospectively entered and stored in a Microsoft
Access database. Plausibility, accuracy, and completeness were
verified.
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